Good News: GenChem & GenPharm (Changzhou) Co., Ltd. Approved for National Post‑doctoral Research Station

作者： 点击：0 发布时间：2026-10-12

   Recently, GenChem & GenPharm (Changzhou) Co., Ltd. has obtained official approval to set up a National Post‑doctoral Research Station, endorsed by the Ministry of Human Resources and Social Security and the National Post‑doctoral Management Committee. Three years after launching its provincial‑level Post‑doctoral Innovation Practice Base in 2023, the company has completed its upgrade from a provincial base to a national‑level station, further refining its talent‑development system for high‑calibre researchers.

    Administered under filing oversight by the Ministry of Human Resources and Social Security and the National Post‑doctoral Management Committee, the National Post‑doctoral Research Station is a national‑level talent and research‑innovation platform within China’s post‑doctoral system. It serves industrial‑innovation entities including enterprises and new‑type R&D institutions. Station establishment follows strict eligibility screening, rigorous evaluation and dynamic management mechanisms. It connects top‑tier academic expertise from universities and research institutes with front‑line industrial R&D within enterprises, acting as a fertile ground for high‑level young talents to thrive and for industry‑university‑research collaboration to deliver tangible outcomes.

    The upgrade from a provincial innovation practice base to a national post‑doctoral research station marks only a new starting point. Seizing this opportunity, GenChem & GenPharm (Changzhou) Co., Ltd. will deepen cooperation with universities and research institutes, jointly recruit and train post‑doctoral researchers, and advance deep‑going industry‑university‑research integration as well as the commercial translation of scientific and technological achievements.